RenovoRx

+$0.12 (+2.04%) As of 3:57 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RenovoRx and other ETFs, options, and stocks.

About RNXT

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for the local treatment of solid tumors. Its therapy platform, RenovoRx, handles the optimizing drug concentration in solid tumors using approved small molecule chemotherapeutics that enable physicians to isolate segments of the vascular anatomy closest to tumors and force chemotherapy across the blood vessel wall to bathe these difficult-to-reach tumors in chemotherapy.

CEO
Shaun R. Bagai
Employees
—
Headquarters
Los Altos, California
Founded
2009

RNXT Key Statistics

Market Cap
50.31M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
215.36K
High Today
$6.00
Low Today
$5.80
Open Price
$5.88
Volume
58.74K
52 Week High
$16.74
52 Week Low
$5.37

RNXT Earnings

Q3 FY21
Estimated
— per share
Actual
Expected Oct 29, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure